ArticleFrontiers in immunology2025

Case report: Long-term survival in synchronous double primary malignancies of lung adenocarcinomas and esophageal squamous cell carcinoma treated with definitive chemoradiotherapy and SBRT combined with anti-PD-1.

Rui Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.